University Medical Center Groningen: COVID-19 trials

The registry lists 13 COVID-19 studies with University Medical Center Groningen as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19Not yet recruitingNCT06911476
• The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 PatientsCompletedNCT06282627
• 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19CompletedNCT05981885
• PREPARE-iVAC TrialCompletedNCT05924685Phase 4
• The Impact of the COVID-19 Pandemic on the Patient in Need of an InterventionCompletedNCT05736822
• Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of CareCompletedNCT05126498
• Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)Status unknownNCT05124483Phase 2
• RECOVAC Repeated Vaccination StudyCompletedNCT05030974Phase 4
• RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease PatientsCompletedNCT04841785
• The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) StudyCompletedNCT04741386
• Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT StudyCompletedNCT04681092Phase 1/2
• COVID-19 Follow up Intensive Care StudiesCompletedNCT04460170
• Nasal Epithelial Genetic and Single Cell RNA COVID-19 StudyWithdrawnNCT04359459